| 糖尿病黄斑水肿患者白内障围手术期应用抗VEGF药物的疗效观察 |
| |
| 引用本文： | 刘宏卓,王培玉,方梦园,万文萃.糖尿病黄斑水肿患者白内障围手术期应用抗VEGF药物的疗效观察[J].眼科新进展,2022,0(2):128-131. |
| |
| 作者姓名： | 刘宏卓 王培玉 方梦园 万文萃 |
| |
| 作者单位： | 450052 河南省郑州市，郑州大学第一附属医院眼科 |
| |
| 基金项目： | 国家自然科学基金青年基金项目(编号8210040956)。 |
| |
| 摘 要： | 目的 观察糖尿病黄斑水肿(DME)患者真实世界中白内障手术前后玻璃体内注射抗血管内皮生长因子(VEGF)药物的效果,进而观察DME患者白内障围手术期积极接受玻璃体内注射抗VEGF药物疗效.方法 回顾性临床队列研究.回顾性分析2018年1月至2021年5月在郑州大学第一附属医院眼二科接受白内障超声乳化手术和玻璃体内注射抗...
|
| 关 键 词： | 糖尿病黄斑水肿 白内障手术 抗血管内皮生长因子 最佳矫正视力 黄斑中央凹厚度 |
Efficacy of anti-vascular endothelial growth factor drugs in diabetic macular edema patients during the perioperative period of cataract surgery |
| |
| LIU Hongzhuo,WANG Peiyu,FANG Mengyuan,WAN Wencui.Efficacy of anti-vascular endothelial growth factor drugs in diabetic macular edema patients during the perioperative period of cataract surgery[J].Recent Advances in Ophthalmology,2022,0(2):128-131. |
| |
| Authors: | LIU Hongzhuo WANG Peiyu FANG Mengyuan WAN Wencui |
| |
| Affiliation: | Department of Ophthalmology，the First Affiliated Hospital of Zhengzhou University， Zhengzhou 450052,Henan Province，China |
| |
| Abstract: | Objective To investigate the effect of intravitreal injections of anti-vascular endothelial growth factor(VEGF)drugs before and after cataract surgery in patients with diabetic macular edema(DME)in the real world and the efficacy of anti-VEGF drugs during the perioperative period.Methods This study was a retrospective clinical cohort study.All patients who underwent cataract surgery and intravitreal injection of anti-VEGF drugs in the First Affiliated Hospital of Zhengzhou University from January 2018 to May 2021 were analyzed.There were 88 patients(88 eyes)diagnosed as DME combined with cataract within 6 months before surgery receiving cataract surgery and at least one intravitreal injection of anti-VEGF drugs.Outcome measures included the development of subretinal or intraretinal fluid at 1 and 6 months postoperatively,injection time,number of injections,best corrected visual acuity(BCVA),and central subfield thickness(CST).Results Preoperative BCVA(logMAR)was 2.40±0.49,and postoperative BCVA(logMAR)was 1.02±0.70 and 0.80±0.63,respectively,at 1 month and 6 months after surgery.Postoperative BCVA improved significantly in all eyes(all P<0.05).CST of all eyes was(335.364±54.44)μm,(226.37±84.85)μm,and(213.63±91.92)μm before surgery,1 month and 6 months after surgery,respectively.The difference was not statistically significant(P>0.05).Preoperative optical coherence tomography showed fluid in 88 eyes(100.00%).Forty eyes(45.45%)developed new or worsened subretinal or intraretinal fluid,while for these eyes,there was no significant difference in CST before and after surgery(P>0.05),and the postoperative visual acuity significantly improved(P<0.05).Conclusion In the real-world setting,DME patients with cataract can receive cataract surgery,and their BCVA will not be affected by worsening DME as long as they follow the anti-VEGF treatment. |
| |
| Keywords: | diabetic macular edema cataract surgery anti-vascular endothelial growth factor best corrected visual acuity central subfield thickness |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《眼科新进展》浏览原始摘要信息 |
|
点击此处可从《眼科新进展》下载全文 |
|
